Global Lung Health research at LSTM
Of the 10 million people who die each year from lung diseases, some 80 percent live in these resource-limited settings.
Addressing issues around lung health in Africa, the continent most afflicted by morbidity and death from respiratory diseases.
LSTM’s global lung health programme takes a holistic, person-centered perspective, recognising that men and women, boys and girls experience a heavy burden of lung disease which manifests with a range of symptoms as disabling as coughing, breathlessness, and wheezing.
The causes of these problems are complex, very often rooted in poverty, and include infections such as Mycobacterium tuberculosis and Streptococcus pneumonia, and non-communicable conditions such as asthma and chronic obstructive pulmonary disease.
The solutions require multi-disciplinary collaborations aimed at both prevention and management of the full spectrum of communicable and non-communicable lung conditions.